Abstract:Breast cancer (BC) is the most common invasive cancer in women. M2 macrophage exosomes promote cancer development and play multiple roles in the tumor microenvironment, but the mechanism of action by which M2 macrophage exosomes promote BC remains unclear. Therefore, the purpose of this study was to investigate the mechanism by which M2 macrophage-derived exosomes promote the development of breast cancer. We collected BC tissues and determined the expression of LINC00470, followed by the establishment of M2 macrophages in culture and the isolation and identification of M2 macrophage exosomes. Next, we investigated the effects of M2 macrophage exosomes on BC cell proliferation, invasion, miR-199a-3p promoter methylation, and the expression of LINC00470, myc, DNMT3A, and miR-199a-3p. Finally, LINC00470 expression was inhibited in M2 macrophage exosomes, while miR-199a-3p expression was inhibited in BC cells, and changes in BC cell proliferation, invasion, miR-199a-3p promoter methylation, and the expression of LINC00470, myc, DNMT3A, and miR-199a-3p were analyzed. We demonstrated that LINC00470 was highly expressed in BC tissues, M2-type macrophages were successfully induced in vitro, and Dil-labeled M2 macrophage exosomes could successfully enter MDA-MB-231 and MCF-7 cells. Coculture of M2 macrophage exosomes with MDA-MB-231 and MCF-7 cells significantly enhanced the proliferation and invasion of MDA-MB-231 and MCF-7 cells, upregulated the expression of LINC00470, myc, and DNMT3A and downregulated the expression of miR-199a-3p. Moreover, the inhibition of LINC00470 expression in M2 macrophage exosomes significantly downregulated the expression of LINC00470, myc, and DNMT3A in MDA-MB-231 and MCF-7 cells, upregulated the expression of miR-199a-3p, and hypomethylated the promoter of the miR-199a-3p locus. Moreover, inhibition of LINC00470 expression in M2 macrophage-derived exosomes significantly attenuated the proliferation and invasive ability of MDA-MB-231 and MCF-7 cells, while miR-199a-3p inhibitor transfection reversed this effect. Collectively, these findings indicated that M2-type macrophage-derived exosomes promote BC proliferation and migration by regulating miR-199a-3p promoter methylation through the LINC00470-mediated myc/DNMT3a axis.

MYC and DNMT3A‐mediated DNA Methylation Represses Microrna‐200b in Triple Negative Breast Cancer

The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1

DNMT1 and EZH2 Mediated Methylation Silences the Microrna-200B/a/429 Gene and Promotes Tumor Progression.

MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer

Bioinformatics Identification of Dysregulated Micrornas in Triple Negative Breast Cancer Based on Microrna Expression Profiling.

Epigenetically Deregulated Mir-200C is Involved in a Negative Feedback Loop with DNMT3a in Gastric Cancer Cells.

M2 Macrophage-Derived Exosomes Regulate miR-199a-3p Promoter Methylation Through the LINC00470-Mediated myc/DNMT3a Axis to Promote Breast Cancer Development

Methylation-mediated Silencing of Mir-133A-3p Promotes Breast Cancer Cell Migration and Stemness Via Mir-133A-3p/maml1/dnmt3a Positive Feedback Loop

Methylation-dependent MCM6 repression induced by LINC00472 inhibits triple-negative breast cancer metastasis by disturbing the MEK/ERK signaling pathway

Companion Diagnostics and Cancer Biomarkers miR-185 Suppresses Tumor Proliferation by Directly Targeting E 2 F 6 and DNMT 1 and Indirectly Upregulating BRCA 1 in Triple-Negative Breast Cancer

MicroRNA 34c Gene Down-Regulation Via DNA Methylation Promotes Self-Renewal and Epithelial-Mesenchymal Transition in Breast Tumor-Initiating Cells.

The Micrornas Mir-200B-3p and Mir-429-5p Target the LIMK1/CFL1 Pathway to Inhibit Growth and Motility of Breast Cancer Cells

Tumor Suppressive Microrna-193B Promotes Breast Cancer Progression Via Targeting DNAJC13 and RAB22A.

RETRACTED ARTICLE: MiR-140-5p Inhibits Cell Proliferation and Metastasis by Regulating MUC1 Via BCL2A1/MAPK Pathway in Triple Negative Breast Cancer

DNMT1 Recruited by EZH2-mediated Silencing of Mir-484 Contributes to the Malignancy of Cervical Cancer Cells Through MMP14 and HNF1A

MicroRNAs-mediated Cell Fate in Triple Negative Breast Cancers

The Mechanism of DNA Methylation and miRNA in Breast Cancer

MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer.

MicroRNA-301b Promotes Cell Proliferation and Apoptosis Resistance in Triple-Negative Breast Cancer by Targeting CYLD

Identification of Dysregulated Micrornas in Triple-Negative Breast Cancer (Review).